A Study Evaluating the Safety and Efficacy of Tirofiban in Combination With Alteplase in Acute Ischemic Stroke
Status:
Recruiting
Trial end date:
2023-06-30
Target enrollment:
Participant gender:
Summary
The study is a prospective, multicenter, randomized, double-blind, placebo-controlled study
evaluating the safety and efficacy of tirofiban in combination with intravenous thrombolytic
therapy with alteplase in acute ischemic stroke